Behavioral Telehealth Loses Momentum Without a Regulatory Boost
As flexible treatment options spurred by the covid pandemic wane, patients relying on medications classified as controlled substances worry that without action to extend the loosened rules, it’ll be harder to get their meds.
http://dlvr.it/SgfJFg
http://dlvr.it/SgfJFg
Comments
Post a Comment